Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. (Q44776010)
Jump to navigation
Jump to search
scientific article published on 24 February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. |
scientific article published on 24 February 2004 |
Statements
1 reference
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. (English)
1 reference
Lorenz Trümper
1 reference
Marita Kloess
1 reference
Rudolf Schmits
1 reference
Alfred C Feller
1 reference
Christian Rudolph
1 reference
Marcel Reiser
1 reference
Dieter K Hossfeld
1 reference
Bernd Metzner
1 reference
Dirk Hasenclever
1 reference
Norbert Schmitz
1 reference
Bertram Glass
1 reference
Christian Rübe
1 reference
Markus Loeffler
1 reference
German High-Grade Non-Hodgkin's Lymphoma Study Group
1 reference
24 February 2004
1 reference
Identifiers
1 reference